Boston Scientific, a leading medical technology company based in the United States, has announced its plans to invest €80 million in expanding its manufacturing and research and development capabilities in Clonmel, Ireland. As a result of this investment, the company will create over 400 new jobs in the region.
Boston Scientific is already the largest life sciences employer in Ireland, with over 6,500 employees across Galway, Cork, and Clonmel. The new jobs will have a significant impact on the region, as Boston Scientific employees manufacture medical devices for over 400,000 patients globally each year. These devices are used to treat heart disease, neurological disorders, kidney stones, and diseases of the pancreas, bile ducts, and esophagus.
The investment will also enable the company to transition to renewable energy sources, which aligns with its commitment to sustainability and environmental responsibility. This move is expected to have a positive impact on the environment and further cement Boston Scientific’s reputation as a socially responsible company.
Key Takeaways
- Boston Scientific is investing €80 million in expanding manufacturing and R&D capabilities in Clonmel, Ireland, which will significantly increase office and manufacturing space and transition to more than 90% renewable energy sources.
- The investment is expected to create over 400 new jobs in the region, in various areas, and will have a ripple effect on the wider community.
- Boston Scientific is already the largest life sciences employer in Ireland with over 6,500 employees across Galway, Cork, and Clonmel, and this investment is expected to further strengthen its position in the country.
- Boston Scientific’s employees manufacture medical devices for over 400,000 patients globally each year, and the investment will lead to the development of new, life-saving products, while also demonstrating the company’s commitment to sustainability and environmental responsibility.
Company Overview
Boston Scientific is a US-based medical technology company that has been operating in Ireland since 1994. It is currently the largest life sciences employer in the country and has over 6,500 employees across Galway, Cork, and Clonmel.
The products manufactured by Boston Scientific are used to treat heart disease, neurological disorders, kidney stones, and diseases of the pancreas, bile ducts, and esophagus. The company’s employees manufacture medical devices for over 400,000 patients globally each year.
The company plans to expand its manufacturing and research and development capabilities with an investment of €80m, which includes transitioning to more than 90% renewable energy sources. This move is expected to have a positive impact on the environment and also create over 400 new jobs in Clonmel.
The investment and job creation have been welcomed by the Taoiseach Leo Varadkar, who sees it as a show of confidence in Ireland’s life sciences sector, while Mary Buckley is excited about the new opportunities and careers that will be created in Tipperary and the region. Conor Russell credits the talented workforce in Clonmel for the company’s growth, and this new investment is expected to strengthen Boston Scientific’s position as a major player in the medical technology industry.
Investment Details
The investment of €80 million by Boston Scientific is set to significantly expand their manufacturing and research and development capabilities, as well as increase office and manufacturing space. The company’s transition to more than 90% renewable energy sources marks a major step towards achieving sustainable production.
With this investment, Boston Scientific is expected to further strengthen its position as the largest life sciences employer in Ireland. The expansion of Boston Scientific’s operations in Clonmel is also expected to create over 400 new jobs in various areas.
This move is significant not only for the company’s growth but also for the positive impact it will have on the local economy. The products manufactured in Clonmel are vital in treating various medical conditions, and the company’s investment in research and development will undoubtedly lead to the development of new, life-saving products.
Overall, this investment is a testament to the company’s commitment to Ireland’s life sciences sector and its contributions to improving the lives of patients globally.
Impact and Reactions
The impact of Boston Scientific’s investment in Ireland’s life sciences sector and the creation of over 400 new jobs has been met with positive reactions from industry experts and government officials alike.
The medical technology company’s expansion plans include increasing office and manufacturing space and transitioning to more than 90% renewable energy sources. This commitment to sustainable practices is especially noteworthy given the environmental impact of the medical device industry.
Furthermore, the products manufactured by Boston Scientific’s employees in Ireland play a crucial role in treating a wide range of medical conditions, including heart disease and neurological disorders. The company’s investment will not only boost the local economy but also benefit patients around the world.
As Conor Russell, Vice President of Manufacturing for Boston Scientific in Clonmel notes, the talented workforce in the region has helped drive the company’s growth. The investment is a positive sign for the future of the life sciences sector in Ireland, and the new job opportunities will undoubtedly have a ripple effect on the wider community.
